NEW YORK, NY, December 07, 2023 - PRISM MediaWire - US equities are settling mostly higher in Thursday midday trading, with big tech broadly higher as Google ($GOOG) rallies after the company’s launch of Project Gemini, an AI model trained to behave in human-like ways. Airlines, including JetBlue ($JBLU), credit cards and chemicals are performing well.
Gemini: Google ups the stakes in AI race with a technology trained to behave like humans | AP News
Google took its next leap in artificial intelligence Wednesday with the launch of project Gemini, an AI model trained to behave in human-like ways that’s likely to intensify the debate about the technology’s potential promise and perils.
Read More
Notable gainers for the day include Verint Systems ($VRNT) which is up +21.6% on positive Q3 earnings, Semtech($SMTC), which rose +17.9% also following strong Q3 earnings and expected strong high-end consumer net sales, and JetBlue Airways ($JBLU), up +13% after the airline raised revenue guidance and noted healthy travel demand, outperformance in close-in bookings, and solid operational performance.
The day’s decliners are Sprinklr ($CXM), down (31.7%) after being downgraded to Neutral from Buy at BTIG, Methode Electronics ($MEI) which fell (12.7%) following big earnings misses attributed to headwinds related to auto program roll offs, a difficult year in Asia, continued softness in the e-bike market, and continued impact from the UAW strike. C3.ai ($AI) is down (11.5%) after reaffirming its FY24 revenue guidance but cutting operating income, and with R&D and sales costs that will add additional challenges to the company achieving its cash flow positive goal by FY25.
About PRISM MarketView:
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
PRISM MarketView does not provide investment advice.
Contact:
SOURCE: PRISM MarketView
PRISM MarketView - Social Media